AN2 Therapeutics, Inc. — All Filings
346 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
3/A
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | 4 | 0001193125-25-270255 | Nov 6, 2025 | Nov 4, 2025 |
| 4 | 4 | 0001193125-25-238984 | Oct 14, 2025 | Oct 10, 2025 |
| 4 | 4 | 0001193125-25-238982 | Oct 14, 2025 | Oct 10, 2025 |
| 4 | 4 | 0001193125-25-238983 | Oct 14, 2025 | Oct 10, 2025 |
| 8-K | 8-K | 0000950170-25-107278 | Aug 12, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-107301 | Aug 12, 2025 | Jun 30, 2025 |
| 4 | 4 | 0000950170-25-095408 | Jul 11, 2025 | Jul 10, 2025 |
| 4 | 4 | 0000950170-25-095403 | Jul 11, 2025 | Jul 10, 2025 |
| 4 | 4 | 0000950170-25-095406 | Jul 11, 2025 | Jul 10, 2025 |
| 8-K | 8-K | 0001193125-25-143187 | Jun 20, 2025 | Jun 17, 2025 |
| SCHEDULE 13D/A | — | 0001373604-25-000092 | Jun 18, 2025 | — |
| 4 | — | 0001373604-25-000090 | Jun 16, 2025 | Jun 12, 2025 |
| 8-K | 8-K | 0001193125-25-138796 | Jun 11, 2025 | — |
| SCHEDULE 13G | — | 0000935836-25-000414 | Jun 4, 2025 | — |
| 4 | 4 | 0000950170-25-081041 | Jun 3, 2025 | Jun 2, 2025 |
| 4 | — | 0001373604-25-000084 | May 30, 2025 | May 28, 2025 |
| SCHEDULE 13D/A | — | 0001373604-25-000086 | May 30, 2025 | — |
| 4 | 4 | 0000950170-25-078982 | May 29, 2025 | May 28, 2025 |
| 8-K | 8-K | 0001193125-25-127595 | May 27, 2025 | May 22, 2025 |
| 4 | 4 | 0000950170-25-077061 | May 23, 2025 | May 22, 2025 |
| 4 | 4 | 0000950170-25-077035 | May 23, 2025 | May 22, 2025 |
| 4 | 4 | 0000950170-25-077062 | May 23, 2025 | May 22, 2025 |
| 4 | 4 | 0000950170-25-077053 | May 23, 2025 | May 22, 2025 |
| 4 | 4 | 0000950170-25-077058 | May 23, 2025 | May 22, 2025 |
| 4 | 4 | 0000950170-25-077070 | May 23, 2025 | May 22, 2025 |
| 4 | 4 | 0000950170-25-077073 | May 23, 2025 | May 22, 2025 |
| 4 | 4 | 0000950170-25-077036 | May 23, 2025 | May 22, 2025 |
| 8-K | 8-K | 0000950170-25-070305 | May 13, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-070358 | May 13, 2025 | Mar 31, 2025 |
| SCHEDULE 13D | — | 0001373604-25-000074 | May 7, 2025 | — |
| 8-K | 8-K | 0001193125-25-110019 | May 1, 2025 | — |
| 4 | 4 | 0000950170-25-053367 | Apr 11, 2025 | Apr 10, 2025 |
| 4 | 4 | 0000950170-25-053373 | Apr 11, 2025 | Apr 10, 2025 |
| ARS | ARS | 0000950170-25-052971 | Apr 11, 2025 | Dec 31, 2024 |
| 4 | 4 | 0000950170-25-053348 | Apr 11, 2025 | Apr 10, 2025 |
| 4 | 4 | 0000950170-25-053355 | Apr 11, 2025 | Apr 10, 2025 |
| DEFA14A | DEFA14A | 0000950170-25-052853 | Apr 10, 2025 | — |
| DEF 14A | DEF 14A | 0000950170-25-052852 | Apr 10, 2025 | — |
| 8-K | 8-K | 0000950170-25-044353 | Mar 25, 2025 | — |
| 10-K | 10-K | 0000950170-25-044366 | Mar 25, 2025 | Dec 31, 2024 |
| S-8 | S-8 | 0000950170-25-044432 | Mar 25, 2025 | — |
| 4 | 4 | 0000950170-25-030041 | Feb 28, 2025 | Feb 26, 2025 |
| 4 | 4 | 0000950170-25-030032 | Feb 28, 2025 | Feb 26, 2025 |
| SCHEDULE 13G/A | — | 0000950170-25-030289 | Feb 28, 2025 | — |
| 4 | 4 | 0000950170-25-030042 | Feb 28, 2025 | Feb 26, 2025 |
| 4 | 4 | 0000950170-25-030052 | Feb 28, 2025 | Feb 26, 2025 |
| 4 | 4 | 0000950170-25-030057 | Feb 28, 2025 | Feb 26, 2025 |
| SCHEDULE 13G/A | — | 0001104659-25-014185 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-021346 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001415889-25-004263 | Feb 14, 2025 | — |